It is privilege to write for this inaugural ISSHP newsletter. Life’s perfect partnership starts with the placenta. If we get this right, we have the best chance of healthy life. In preeclampsia, we have a failing placenta. Preeclampsia kills one pregnant woman every minute and the life expectancy of those who survive is greatly reduced.

ISSHP Membership Reminder We have recently made improvements to how your membership of the society works. In response to your feedback, we have made it possible to pay your annual subscription by credit card. Annual subscriptions are due so if you haven't already, please log on to the website to arrange payment and please take a minute to update

In this regular lighthearted Q and A, we find out how members of ISSHP spend their off duty hours, starting with our President, Mark Brown

I’ll bet you were wondering whether it was worth opening up yet another ‘Newsletter’ as we seem to get these in all sorts of formats and guises these days. I suspect most often they go direct to the ‘delete’ section of our devices. So thanks for reading this piece as we spent a bit of

October 26, 2014 – New Orleans, La. – The International Society for the Study of Hypertension in Pregnancy (ISSHP) and the Preeclampsia Foundation tonight announced a collaborative program at the 2014 ISSHP World Congress to advance research in the field of hypertension in pregnancy. EMpowering Progress in Obstetric and Women’s hEalth Research (EMPOWER) creates and supports partnerships between seasoned investigators and young investigators in low resource settings to improve research capacity, primarily in the area of high blood pressure in pregnancy. Preeclampsia, the most dangerous form of pregnancy hypertension, is estimated to contribute to at least 120 maternal and 1300 fetal or newborn deaths every day throughout the world, primarily in regions such as the Indian subcontinent, Africa and Latin America. Most of these cases are considered preventable.

One of ISSHP´s aims is to develop research and clinical changes that improve management for pregnant women with hypertension in low and middle income countries (LMIC). To this end ISSHP has formed a small group to advise Council on practical ways ISSHP can engage in such plans. More information will be presented during the 2014 World Meeting in New Orleans.

The Preeclampsia Foundation is currently accepting applications for their 2014 Vision Grant award program. This year, up to two medical research grants will be awarded, totaling up to $25,000 each. The application deadline is May 16, 2014, with award notification by August 22, 2014

A Eulogy and Tribute to Andrea  Luigi Tranquilli Professor Andréa Tranquilli died 12th January 2014 and Italy has lost an outstanding obstetrician/Gynecologist, brilliant, teacher, mentor, and  exceptional researcher.  Simultaneously the International Society for the Study of Hypertension (ISSHP) lost its current president, a visionary leader, while we lost a dear friend, virtually a  brother whom each of us have

We circulated a questionnaire to the International Committee of the International Society for the Study of Hypertension in Pregnancy focusing on the thresholds for defining severe preeclampsia and the gestation at which to define early-onset preeclampsia, and on the definition and inclusion of the HELLP syndrome or other clinical features in severe preeclampsia. The questions were closed, but all answers had space for more open detailed comments.

Personalised medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome (IMproved PRegnancy Outcomes by Early Detection).